Visit Watson-Marlow Fluid Technology Solutions at booth 3521 during INTERPHEX 2024 for exclusive technology previews and insights

Devens, MA, USA, 25th March 2024 / Sciad / Watson-Marlow Fluid Technology Solutions (WMFTS) will preview two new technologies at booth 3521 during INTERPHEX 2024, 16-18th April 2024, Javits Center, NYC, USA.  

The new solutions further expand WMFTS’s range of comprehensive fluid path technologies and have been developed to provide optimal precision and control for the biopharmaceutical and OEM markets. 

WMArchitect^TM single-use solutions, a new range of fluid path innovations, will be exclusively launched at INTERPHEX 2024. Visitors to the booth can discover how WMArchitect can reduce risk, ensure quality and improve delivery times for biopharmaceutical companies. 

There will be a preview of WMFTS’s latest OEM peristaltic pump solution prior to global launch this year. DriveSure features next generation digital closed-loop control technology which delivers enhanced speed control for accurate flow rates, coupled with cool and quiet performance. This complete solution enables OEMs to reduce time-to-market and achieve competitive gain by simplifying each stage of the development process. 

WMFTS’s precision-engineered peristaltic pumps and critical fluid path technologies for scalable drug substance bioprocess and small-batch drug product fill/finish applications will also be on show, including WM pumps, the Flexicon PF7+ and FPC60. 

Elsewhere at the New York event, Katie Church, Commercial Validation Manager at WMFTS, will share her expertise in two presentations as part of the INTERPHEX 2024 speaker program.  

Speaking on the importance of ‘Forming Confident Connections in your Fluid Pathway’, Katie will explain how compatible components can be confidently interchanged and support scale-up demands as well as supply chain disruptions. Katie will also be presenting ‘Reducing Bottlenecks and Accelerating Biologics Speed to Patient’ which will focus on considerations when implementing flexible manufacturing equipment to accelerate biologics production. 

Throughout the show at their booth, WMFTS engineers will deliver a series of solutions-focused talks, with tips on how to overcome common challenges in fluid transfer applications, ensure compliance, process stability and final product quality. 

Visit booth 3521 for a pre-launch demonstration of WMFTS’s new fluid path technologies and see how the company supports the advancement of bioprocesses from end to end. 

ENDS

For further information, please contact:

Lauren Gill, PR Manager  
Watson-Marlow Fluid Technology Solutions  
E: lauren.gill@wmfts.com

Sciad Communications, Media Relations 
Juliette Craggs / Jasmin Shearan
E: watsonmarlow@sciad.com
T: +44 (0)20 3405 7892 

Notes for Editors

About Watson-Marlow Fluid Technology Solutions  

Watson-Marlow Fluid Technology Solutions (WMFTS) is a world leader in manufacturing peristaltic pumps and associated fluid path technologies for the life sciences and process industries. WMFTS is part of Spirax Group (Spirax-Sarco Engineering plc), with 47 operating units worldwide. Further information can be found at www.wmfts.com.